<DOC>
	<DOCNO>NCT01269463</DOCNO>
	<brief_summary>The time course response follow one dose new methylphenidate hydrochloride extend release capsule study child 6-12 year simulate laboratory classroom set . Biphentin methylphenidate hydrochloride extend release capsule formulate daily dose provide treatment child ADHD substantial day .</brief_summary>
	<brief_title>Time Course Response Methylphenidate HCl ER Capsules Children 6 12 Years With ADHD Classroom Setting</brief_title>
	<detailed_description>Biphentin methylphenidate hydrochloride extend release capsule provide multiple strength 10 , 15 , 20 , 30 , 40 , 50 , 60 mg administer daily . Once daily dose intend provide treatment substantial day . For current analog classroom study eligible subject optimize 15 , 20 , 30 , 40 mg timeframe five weekly period . In sixth week subject randomize double-blind receive either active comparator optimize dose placebo comparator treatment . The first classroom session hold end week , efficacy measurement include SKAMP PERMP test administer . At begin follow week , subject crossed-over correspond active comparator placebo comparator treatment . The second classroom session hold end second double-blind week , efficacy measurement administer . Various safety tolerability , quality life assessment conduct .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Males female age 6 12 . 2 . ADHD diagnosis ADHDRSIV score â‰¥ 90th percentile . 3 . In need treatment ADHD able 2day washout previous medication . 4 . Females childbearing potential pregnant practice birth control . 5 . Subject parent/guardian willing comply protocol . 6 . Signed consent assent . 1 . IQ le 80 WASI . 2 . Current primary psychiatric diagnosis : severe anxiety disorder , conduct disorder , psychotic disorder , pervasive developmental disorder , eat disorder , obsessivecompulsive disorder , major depressive disorder , bipolar disorder , substance use disorder , chronic tic disorder , personal family history Tourette 's Syndrome . 3 . Chronic medical illness : seizure , hypertension , thyroid disease , cardiac , family history sudden death , glaucoma . 4 . Use psychotropic CNS med effect exceed 14 day screen . 5 . Planned use prohibit drug . 6 . Is pregnant breastfeeding . 7 . Significant ECG laboratory abnormality . 8 . Experimental drug medical device within 30 day prior screen . 9 . Hypersensitivity methylphenidate . 10 . Inability unwillingness comply protocol . 11 . Well controlled current ADHD treatment . 12 . Inability take oral capsule .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Attention deficit</keyword>
	<keyword>Hyperactivity</keyword>
	<keyword>Impulsivity</keyword>
	<keyword>Inattention</keyword>
</DOC>